HolderBook

IMMUNOME INC (IMNM)

Institutional ownership reported to the SEC as of Q3 2026, across 24 quarters.

4
Reporting holders
$117.9K
Reported value
0.0%
Calls
0.0%
Puts
-202
Holder change

Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.

Holders

Download these holders as CSV

FilerValueShares Their book Held Change
GK Wealth Management LLC$70.5K3,2790.04%newNEW
GAMMA Investing LLC$46.5K2,1640.00%9q+28.8%+$10.4K
Versant Capital Management, Inc$495230.00%newNEW
Farther Finance Advisors, LLC$323150.00%4qHELD

Five percent filings

Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →

FiledFormFiler % of class
2026-08-1413G/ASirenia Capital Management LPwith 1 co-filers4.3%
2026-08-1413G/AT. Rowe Price Investment Management, Inc.17.4%

What the company announced

Form 8-K filings from the last 120 days, showing only the items worth a reader's attention. Earnings releases, exhibit attachments and general disclosures are filed constantly and are left out. Filed is when the SEC received it; event is the date the company says the thing happened.

FiledEvent dateWhatSource
2026-10-052026-10-02Material agreement enteredfiling

What the insiders did

Open market purchases and sales reported on Form 4 in the last 180 days. Grants, option exercises and shares surrendered to cover tax are left out: they are compensation rather than a decision to buy or sell. Where a broker filled one order in tranches the lines are summed, because it was one decision.

Officers and directors

DateInsiderRoleSideSharesValue
2026-08-04Horn KinneyCHIEF BUSINESS OFFICERSold90,616$2.3M
2026-07-02Barchas IsaacDirectorSold100,000$2.3M ×2
2026-06-30Barchas IsaacDirectorSold101,050$2.1M
2026-07-06Barchas IsaacDirectorSold83,094$2.0M
2026-08-11Barchas IsaacDirectorSold62,291$1.6M
2026-07-02Lechleider RobertChief Medical OfficerSold55,000$1.2M ×3
2026-06-15Rosett MaxChief Financial OfficerSold60,000$1.1M
2026-06-25Lechleider RobertChief Medical OfficerSold55,000$1.1M ×2
2026-08-06Barchas IsaacDirectorSold20,840$543.1K
2026-07-07Barchas IsaacDirectorSold16,906$409.1K
2026-08-07Barchas IsaacDirectorSold15,248$397.4K
2026-09-11Higgins JackChief Scientific OfficerSold13,200$334.2K

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q3 20264$117.9K5,4812100.0%
Q2 2026206$2.7B124,751,9103371580.4%
Q1 2026203$2.6B116,878,2954274441.5%
Q4 2025184$2.6B119,595,6644477352.8%
Q3 2025154$1.1B91,417,1652659354.9%
Q2 2025143$779.3M79,433,5232751385.2%
Q1 2025143$548.1M76,963,0153868165.4%
Q4 2024121$588.6M53,313,6652738323.8%
Q3 2024115$788.0M51,653,8112140304.2%
Q2 2024115$588.1M48,434,8093638230.4%
Q1 2024104$928.0M37,504,1135829120.3%
Q4 202358$233.3M21,713,350251660.4%
Q3 202336$23.5M2,729,0769693.3%
Q2 202335$18.9M2,315,15371163.0%
Q1 202330$9.6M1,860,0954372.2%
Q4 202228$4.9M2,100,6484360.2%
Q3 202226$11.0M2,392,6334432.1%
Q2 202226$7.9M2,406,4312361.9%
Q1 202232$20.2M3,443,89835102.0%
Q4 202131$40.2M2,856,48281127.5%
Q3 202134$61.7M2,391,52415665.4%
Q2 202127$41.1M2,376,23812860.0%
Q1 202130$64.7M1,909,24087120.0%
Q4 202025$20.1M2,080,55525000.0%